Biochemical and Biophysical Research Communications, Vol.339, No.3, 964-970, 2006
Functional roles of the two distinct domains of halysase, a snake venom metalloprotease, to inhibit human platelet aggregation
Halysase, a hemorrhagic metalloprotease, has an apparent molecular weight of 66 kDa and belongs to the class P-III snake venom metalloprotease. Class P-III snake venom metalloproteases have multifunctional domains including a protease domain and a disintegrinlike domain. Halysase was able to preferentially hydrolyze the alpha-chain of fibrinogen. Proteolytic activity of the enzyme was completely inhibited by metal chelating agents but not by other typical protease inhibitors. The enzyme principally cleaves X-Leu, X-Tyr, X-Phe, and X-Ala peptide bonds of the oxidized insulin B-chain. Halysase strongly suppresses collagen-induced human platelet aggregation in a dose-dependent manner. Apohalysase that is devoid of its metalloprotease activity was also able to inhibit the platelet aggregation to a certain extent. Experimental evidence clearly indicates that each of the two distinct domains of halysase, the metalloprotease and the disintegrin-like domains, plays its characteristic role to inhibit human platelet aggregation. (c) 2005 Elsevier Inc. All rights reserved.
Keywords:hemorrhagic metalloprotease;snake venom;platelet aggregation;disintegrin-like domain;fibrinogen;collagen